Skip to main content

UBS Group AG

Position in CGON — CG Oncology, Inc.

CIK 1610520 ZURICH, V8

Position in CGON

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$69,465,228
-$19,329,441 QoQ
Shares Held
977,695
-25.5% QoQ
Ownership
1.10%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#25
of 226 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority Sole 97% Shared 0% None 3%

Common Shares in CGON Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,751,270,180 across 562 Biotechnology names. CGON ranks #32 (0.8% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in CGON

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $69,465,228 977,695
2026-03-31 $88,794,669 1,311,978
2025-12-31 $79,873,932 1,923,746
2025-09-30 $85,646,154 2,126,270
2025-06-30 $57,960,370 2,229,245
2025-03-31 $41,748,542 1,704,718
2024-12-31 $29,078,393 1,013,891
2024-09-30 $3,264,927 86,534
2024-06-30 $2,464,985 78,080
2024-03-31 $1,023,879 23,323